These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 26518230)

  • 1. ELISA Detection of Phenazepam, Etizolam, Pyrazolam, Flubromazepam, Diclazepam and Delorazepam in Blood Using Immunalysis® Benzodiazepine Kit.
    O'Connor LC; Torrance HJ; McKeown DA
    J Anal Toxicol; 2016 Mar; 40(2):159-61. PubMed ID: 26518230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of the Availability, Cost, and Motivations for Use over Time of the New Psychoactive Substances-Benzodiazepines Diclazepam, Flubromazepam, and Pyrazolam-in the UK.
    Abouchedid R; Gilks T; Dargan PI; Archer JRH; Wood DM
    J Med Toxicol; 2018 Jun; 14(2):134-143. PubMed ID: 29671244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood concentrations of new designer benzodiazepines in forensic cases.
    Høiseth G; Tuv SS; Karinen R
    Forensic Sci Int; 2016 Nov; 268():35-38. PubMed ID: 27685473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood Concentrations of Designer Benzodiazepines: Relation to Impairment and Findings in Forensic Cases.
    Heide G; Høiseth G; Middelkoop G; Øiestad ÅML
    J Anal Toxicol; 2020 Dec; 44(8):905-914. PubMed ID: 32369173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detectability of designer benzodiazepines in CEDIA, EMIT II Plus, HEIA, and KIMS II immunochemical screening assays.
    Pettersson Bergstrand M; Helander A; Hansson T; Beck O
    Drug Test Anal; 2017 Apr; 9(4):640-645. PubMed ID: 27366870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection and identification of the designer benzodiazepine flubromazepam and preliminary data on its metabolism and pharmacokinetics.
    Moosmann B; Huppertz LM; Hutter M; Buchwald A; Ferlaino S; Auwärter V
    J Mass Spectrom; 2013 Nov; 48(11):1150-9. PubMed ID: 24259203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Organ distribution of diclazepam, pyrazolam and 3-fluorophenmetrazine.
    Lehmann S; Sczyslo A; Froch-Cortis J; Rothschild MA; Thevis M; Andresen-Streichert H; Mercer-Chalmers-Bender K
    Forensic Sci Int; 2019 Oct; 303():109959. PubMed ID: 31546164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Case Study Involving U-47700, Diclazepam and Flubromazepam-Application of Retrospective Analysis of HRMS Data.
    Partridge E; Trobbiani S; Stockham P; Charlwood C; Kostakis C
    J Anal Toxicol; 2018 Nov; 42(9):655-660. PubMed ID: 29945197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Liquid-Chromatography High-Resolution Mass Spectrometry Method for Non-FDA Approved Benzodiazepines.
    van Wijk XMR; Yun C; Hooshfar S; Arens AM; Lung D; Wu AHB; Lynch KL
    J Anal Toxicol; 2019 May; 43(4):316-320. PubMed ID: 30462225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of an LC-MS/MS Method for the Quantification of 13 Designer Benzodiazepines in Blood.
    Mei V; Concheiro M; Pardi J; Cooper G
    J Anal Toxicol; 2019 Oct; 43(9):688-695. PubMed ID: 31436813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent findings and advancements in the detection of designer benzodiazepines: a brief review.
    Wu D; Fu L
    Arh Hig Rada Toksikol; 2022; 74(4):224-231. PubMed ID: 38146763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the Neogen ELISA Benzodiazepine Kit using Clonazepam as the Target Molecule for Blood and Urine.
    Behnke G; Tiscione NB; Rakus J; Richards-Waugh L
    J Anal Toxicol; 2019 Jun; 43(5):399-405. PubMed ID: 30877805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of Cross-Reactivity of Novel Psychoactive Substances with Drug Screen Immunoassays Kits in Whole Blood.
    Mastrovito R; Trail C; Lino M; Cervantes A; Chan-Hosokawa A; Strathmann F; Logan B
    J Anal Toxicol; 2022 Aug; 46(7):726-731. PubMed ID: 34791285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cross-reactivity of Instant-View M-1 for detection of benzodiazepine-related drugs and their metabolites in urine].
    Torikoshi A; Namera A; Arima Y; Toubou H; Tajima T; Shiraishi H; Nagao M
    Chudoku Kenkyu; 2014 Mar; 27(1):33-8. PubMed ID: 24724359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of prescribed and designer benzodiazepines and metabolites in influent wastewater.
    Bade R; Ghetia M; White JM; Gerber C
    Anal Methods; 2020 Jul; 12(28):3637-3644. PubMed ID: 32701083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the designer benzodiazepine diclazepam and preliminary data on its metabolism and pharmacokinetics.
    Moosmann B; Bisel P; Auwärter V
    Drug Test Anal; 2014; 6(7-8):757-63. PubMed ID: 24604775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flubromazolam--A new life-threatening designer benzodiazepine.
    Łukasik-Głębocka M; Sommerfeld K; Teżyk A; Zielińska-Psuja B; Panieński P; Żaba C
    Clin Toxicol (Phila); 2016; 54(1):66-8. PubMed ID: 26585557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous determination of designer benzodiazepines in human serum using non-aqueous capillary electrophoresis - Tandem mass spectrometry with successive multiple ionic - Polymer layer coated capillary.
    Švidrnoch M; Boráňová B; Tomková J; Ondra P; Maier V
    Talanta; 2018 Jan; 176():69-76. PubMed ID: 28917807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of four immunoassay screening devices for detection of benzodiazepine and its metabolites in urine: mainly detection of etizolam, thienodiazepine and its metabolites].
    Namera A; Makita R; Nagao M
    Chudoku Kenkyu; 2011 Mar; 24(1):27-34. PubMed ID: 21485120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of selected designer benzodiazepines by ultra high performance liquid chromatography with high-resolution time-of-flight mass spectrometry and the estimation of their partition coefficients by micellar electrokinetic chromatography.
    Tomková J; Švidrnoch M; Maier V; Ondra P
    J Sep Sci; 2017 May; 40(9):2037-2044. PubMed ID: 28266783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.